An investigator is conducting a study to identify potential risk factors for post-transplant hypertension. The investigator selects post-transplant patients with hypertension and gathers detailed information regarding their age, gender, preoperative blood pressure readings, and current medications. The results of the study reveal that some of the patients had been treated with cyclosporine. This study is best described as which of the following?
Q2
A 64-year-old man presents to his physician for a scheduled follow-up visit. He has chronic left-sided heart failure with systolic dysfunction. His current regular medications include captopril and digoxin, which were started after his last episode of symptomatic heart failure approximately 3 months ago. His last episode of heart failure was accompanied by atrial fibrillation, which followed an alcohol binge over a weekend. Since then he stopped drinking. He reports that he has no current symptoms at rest and is able to perform regular physical exercise without limitation. On physical examination, mild bipedal edema is noted. The physician suggested to him that he should discontinue digoxin and continue captopril and scheduled him for the next follow-up visit. Which of the following statements best justifies the suggestion made by the physician?
Q3
A 35-year-old woman presents as a new patient to a primary care physician. She hasn't seen a doctor in many years and came in for a routine check-up. She has no specific complaints, although she has occasional shortness of breath with mild activity. On physical exam, her vital signs are as follows: HR 80, BP 110/70, RR 14. On auscultation, her lungs are clear with equal breath sounds bilaterally. When listening over the precordium, the physician hears a mid-systolic click followed by a late systolic murmur that is loudest over the apex. Valsalva increases the murmur. Which of the following is NOT a possible complication of this patient's underlying problem?
Q4
A 66-year-old female with hypertension and a recent history of acute ST-elevation myocardial infarction (STEMI) 6 days previous, treated with percutaneous transluminal angioplasty (PTA), presents with sudden onset chest pain, shortness of breath, diaphoresis, and syncope. Vitals are temperature 37°C (98.6°F), blood pressure 80/50 mm Hg, pulse 125/min, respirations 12/min, and oxygen saturation 92% on room air. On physical examination, the patient is pale and unresponsive. Cardiac exam reveals tachycardia and a pronounced holosystolic murmur loudest at the apex and radiates to the back. Lungs are clear to auscultation. Chest X-ray shows cardiomegaly with clear lung fields. ECG is significant for ST elevations in the precordial leads (V2-V4) and low-voltage QRS complexes. Emergency transthoracic echocardiography shows a left ventricular wall motion abnormality along with a significant pericardial effusion. The patient is intubated, and aggressive fluid resuscitation is initiated. What is the next best step in management?
Q5
A 29-year-old man is brought to the emergency room 6 hours after the onset of severe epigastric pain and vomiting. His heart rate is 110/min and blood pressure is 98/72 mm Hg. He is diagnosed with acute pancreatitis, and fluid resuscitation with normal saline is initiated. Which of the following is the most likely immediate effect of fluid resuscitation in this patient?
Q6
A 28-year-old male presents to his primary care physician with complaints of intermittent abdominal pain and alternating bouts of constipation and diarrhea. His medical chart is not significant for any past medical problems or prior surgeries. He is not prescribed any current medications. Which of the following questions would be the most useful next question in eliciting further history from this patient?
Q7
A 70-year-old man with severe ischemic cardiomyopathy (EF 25%) has recurrent ventricular tachycardia despite optimal medical therapy and ICD placement. Cardiac MRI shows a large anteroseptal scar with viable myocardium in the lateral and inferior walls. He has three-vessel coronary disease. His daughter is advocating for heart transplantation, but he has multiple comorbidities including obesity (BMI 37) and active tobacco use. Evaluate the management priority and rationale.
Q8
A 49-year-old woman with myasthenia gravis undergoes CT chest showing a 5 cm anterior mediastinal mass with irregular borders. Biopsy confirms thymoma (WHO type B2). She has well-controlled myasthenic symptoms on pyridostigmine. Staging shows no distant metastases, but the mass abuts the pericardium without clear invasion. Evaluate the optimal treatment approach.
Q9
A 58-year-old man with coronary artery disease requires CABG. Preoperative angiography shows 90% left main stenosis, 95% proximal LAD stenosis, 80% circumflex stenosis, and chronic total occlusion of the RCA with collaterals. He has diabetes, renal insufficiency (Cr 2.1), and previous stroke. Evaluate the optimal grafting strategy to maximize long-term patency and outcomes.
Q10
A 62-year-old man develops sudden onset of severe chest and back pain. CT angiography shows a Stanford Type B aortic dissection extending from just distal to the left subclavian artery to the iliac bifurcation. Blood pressure is 165/95 mmHg, heart rate 88/min. He has no evidence of malperfusion, rupture, or refractory pain. Analyze the initial management strategy.
Mechanical circulatory support devices US Medical PG Practice Questions and MCQs
Question 1: An investigator is conducting a study to identify potential risk factors for post-transplant hypertension. The investigator selects post-transplant patients with hypertension and gathers detailed information regarding their age, gender, preoperative blood pressure readings, and current medications. The results of the study reveal that some of the patients had been treated with cyclosporine. This study is best described as which of the following?
A. Cross-sectional study
B. Retrospective cohort study
C. Prospective cohort study
D. Case series
E. Case-control study (Correct Answer)
Explanation: ***Case-control study***
- A **case-control study** compares individuals with a disease (cases) to individuals without the disease (controls) to identify risk factors retrospectively.
- In this study, the investigator selects post-transplant patients **with hypertension** (the cases) and looks backward at their exposures, including cyclosporine use, to identify potential risk factors.
- The analytical goal of "identifying risk factors" and the observation that **some patients had been treated with cyclosporine** (implying comparison with those who were not) indicates a case-control design.
- Even if controls are not explicitly mentioned, the study design involves analyzing exposure patterns among cases to identify associations with risk factors.
*Case series*
- A **case series** is purely descriptive and involves collecting detailed information on a group of patients with a common condition without any comparison or analytical hypothesis testing.
- While this study does describe patients with post-transplant hypertension, the key difference is the **analytical intent** to identify risk factors, which goes beyond simple description.
- A true case series would simply report clinical characteristics without attempting to establish associations between exposures and outcomes.
*Cross-sectional study*
- A **cross-sectional study** assesses both exposure and outcome simultaneously at a single point in time to determine prevalence.
- This approach would involve surveying a population of post-transplant patients to determine the prevalence of hypertension and associated factors at that moment.
- The study described has already selected patients with the outcome (hypertension), making it retrospective rather than cross-sectional.
*Retrospective cohort study*
- A **retrospective cohort study** examines past data by first classifying patients based on **exposure status** (e.g., cyclosporine use vs. no cyclosporine), then following them forward in time to see who developed the outcome.
- The key difference is that cohort studies **start with exposure** and move to outcome, whereas this study **starts with outcome** (hypertension) and looks back at exposures.
- If the investigator had selected all transplant patients, divided them by cyclosporine exposure, and then determined hypertension rates in each group, it would be a retrospective cohort study.
*Prospective cohort study*
- A **prospective cohort study** identifies a cohort at baseline (before the outcome) and follows them forward in time to observe who develops the outcome.
- This study has already selected patients **with the outcome present**, making it retrospective rather than prospective.
- A prospective design would require identifying transplant patients at the time of transplant and following them over time to see who develops hypertension.
Question 2: A 64-year-old man presents to his physician for a scheduled follow-up visit. He has chronic left-sided heart failure with systolic dysfunction. His current regular medications include captopril and digoxin, which were started after his last episode of symptomatic heart failure approximately 3 months ago. His last episode of heart failure was accompanied by atrial fibrillation, which followed an alcohol binge over a weekend. Since then he stopped drinking. He reports that he has no current symptoms at rest and is able to perform regular physical exercise without limitation. On physical examination, mild bipedal edema is noted. The physician suggested to him that he should discontinue digoxin and continue captopril and scheduled him for the next follow-up visit. Which of the following statements best justifies the suggestion made by the physician?
A. Long-term digoxin therapy produces significant survival benefits in patients with heart failure, but at the cost of increased heart failure-related admissions.
B. Both captopril and digoxin are likely to improve the long-term survival of the patient with heart failure, but digoxin has more severe side effects.
C. Captopril is likely to improve the long-term survival of the patient with heart failure, unlike digoxin.
D. Digoxin does not benefit patients with left-sided heart failure in the absence of atrial fibrillation.
E. Digoxin is useful to treat atrial fibrillation, but does not benefit patients with systolic dysfunction who are in sinus rhythm. (Correct Answer)
Explanation: ***Digoxin is useful to treat atrial fibrillation, but does not benefit patients with systolic dysfunction who are in sinus rhythm.***
- The patient's **atrial fibrillation** was likely triggered by the alcohol binge and has since resolved, suggesting he is now in **sinus rhythm**.
- Digoxin's primary benefit in heart failure with **systolic dysfunction** (HFrEF) is to control ventricular rate in patients with **atrial fibrillation**, but it does not offer survival benefit in HFrEF patients who are in **sinus rhythm** and well-managed with other therapies.
*Long-term digoxin therapy produces significant survival benefits in patients with heart failure, but at the cost of increased heart failure-related admissions.*
- This statement is incorrect; digoxin has been shown to **reduce hospital admissions** for heart failure, but it does **not provide a significant survival benefit** in patients with HFrEF in sinus rhythm.
- The main benefit of digoxin in HFrEF is to improve symptoms and quality of life, alongside reducing hospitalizations, but not prolonging life.
*Both captopril and digoxin are likely to improve the long-term survival of the patient with heart failure, but digoxin has more severe side effects.*
- **Captopril (an ACE inhibitor)** does improve **long-term survival** in heart failure, but **digoxin does not** demonstrably improve survival.
- While digoxin can have side effects, its lack of survival benefit for HFrEF in sinus rhythm is the primary reason for discontinuation, not just side effect severity.
*Captopril is likely to improve the long-term survival of the patient with heart failure, unlike digoxin.*
- This statement is partially correct that **captopril improves survival**, but it does not fully explain the physician's decision to discontinue digoxin.
- The key missing piece is the patient's current **sinus rhythm** and the lack of benefit of digoxin in that specific context for HFrEF.
*Digoxin does not benefit patients with left-sided heart failure in the absence of atrial fibrillation.*
- This statement is nearly correct, but "left-sided heart failure" is broad. It is specifically in patients with **systolic dysfunction (HFrEF)** who are in **sinus rhythm** that digoxin lacks significant benefit beyond symptom control, and does not provide survival benefit.
Question 3: A 35-year-old woman presents as a new patient to a primary care physician. She hasn't seen a doctor in many years and came in for a routine check-up. She has no specific complaints, although she has occasional shortness of breath with mild activity. On physical exam, her vital signs are as follows: HR 80, BP 110/70, RR 14. On auscultation, her lungs are clear with equal breath sounds bilaterally. When listening over the precordium, the physician hears a mid-systolic click followed by a late systolic murmur that is loudest over the apex. Valsalva increases the murmur. Which of the following is NOT a possible complication of this patient's underlying problem?
A. Cerebral embolism
B. Infective endocarditis
C. Atrial fibrillation
D. Bleeding from acquired von Willebrand disease (Correct Answer)
E. Sudden death
Explanation: ***Bleeding from acquired von Willebrand disease***
- The patient's presentation of a **mid-systolic click** followed by a **late systolic murmur** that increases with Valsalva maneuver is characteristic of **mitral valve prolapse (MVP)**.
- While acquired **von Willebrand syndrome (AVWS)** has been rarely reported with MVP, it is **not a characteristic complication** and is far more commonly associated with **aortic stenosis** and other high-shear cardiac lesions.
- Among the listed options, AVWS is the **least typical** complication of MVP, making this the correct answer to a "NOT" question.
*Cerebral embolism*
- Patients with MVP are at a slightly increased risk of **thromboembolic events**, including **cerebral embolism**, particularly in those with mitral regurgitation or atrial fibrillation.
- The structural abnormalities of the valve can promote **platelet aggregation** or the formation of small thrombi that can embolize.
*Infective endocarditis*
- MVP increases the risk of **infective endocarditis**, particularly in cases with significant mitral regurgitation or thickened, redundant valve leaflets (**myxomatous degeneration**).
- The damaged valve surface provides a site for bacterial attachment and colonization.
*Atrial fibrillation*
- MVP, especially when associated with significant **mitral regurgitation** or **left atrial enlargement**, can lead to the development of **atrial fibrillation**.
- The altered hemodynamics and increased atrial pressure can predispose to arrhythmias.
*Sudden death*
- Although rare, **sudden cardiac death** is a recognized complication of MVP, particularly in patients with severe forms, complex ventricular arrhythmias, or significant mitral regurgitation.
- This complication is often linked to serious ventricular arrhythmias, which can be triggered by leaflet elongation, myocardial fibrosis, or papillary muscle abnormalities.
Question 4: A 66-year-old female with hypertension and a recent history of acute ST-elevation myocardial infarction (STEMI) 6 days previous, treated with percutaneous transluminal angioplasty (PTA), presents with sudden onset chest pain, shortness of breath, diaphoresis, and syncope. Vitals are temperature 37°C (98.6°F), blood pressure 80/50 mm Hg, pulse 125/min, respirations 12/min, and oxygen saturation 92% on room air. On physical examination, the patient is pale and unresponsive. Cardiac exam reveals tachycardia and a pronounced holosystolic murmur loudest at the apex and radiates to the back. Lungs are clear to auscultation. Chest X-ray shows cardiomegaly with clear lung fields. ECG is significant for ST elevations in the precordial leads (V2-V4) and low-voltage QRS complexes. Emergency transthoracic echocardiography shows a left ventricular wall motion abnormality along with a significant pericardial effusion. The patient is intubated, and aggressive fluid resuscitation is initiated. What is the next best step in management?
A. Immediate cardiac catheterization
B. Immediate transfer to the operating room (Correct Answer)
C. Emergency pericardiocentesis
D. Intra-aortic balloon counterpulsation
E. Administer dobutamine 5-10 mcg/kg/min IV
Explanation: ***Immediate transfer to the operating room***
- The patient's presentation with sudden onset chest pain, shortness of breath, profound cardiogenic shock, and a new **holosystolic murmur at the apex radiating to the back** in the context of a recent **STEMI**, strongly suggests **acute papillary muscle rupture** causing severe mitral regurgitation. This is a surgical emergency requiring immediate intervention.
- The holosystolic murmur at the apex is pathognomonic for acute mitral regurgitation, distinguishing this from ventricular free wall rupture (which would present with tamponade physiology without a murmur).
- The patient requires urgent surgical repair (mitral valve replacement or repair) to address this mechanical complication of **myocardial infarction (MI)**, which is causing severe hemodynamic compromise.
*Immediate cardiac catheterization*
- While cardiac catheterization is essential for diagnosing coronary artery disease and revascularization, in this emergent situation with profound shock and a mechanical complication (papillary muscle rupture), the primary issue is structural cardiac damage requiring surgical repair, not ongoing ischemia alone.
- Delaying surgical intervention for catheterization in this hemodynamically unstable patient would be detrimental and potentially fatal.
*Emergency pericardiocentesis*
- Although there is a **pericardial effusion** on echocardiography, the patient's presentation with a new holosystolic murmur and profound shock after STEMI indicates **papillary muscle rupture with acute mitral regurgitation**, not cardiac tamponade.
- The presence of a loud murmur excludes ventricular free wall rupture as the primary cause. The effusion is likely reactive or incidental.
- Pericardiocentesis would not address the underlying mitral valve pathology causing the hemodynamic collapse.
*Intra-aortic balloon counterpulsation*
- **Intra-aortic balloon pump (IABP)** can improve cardiac output and reduce afterload, which may provide temporary hemodynamic support in cardiogenic shock.
- However, in cases of **papillary muscle rupture** with severe acute mitral regurgitation, IABP provides only temporary support and does not fix the underlying structural problem.
- It could be considered as a bridge to surgery, but the definitive treatment is surgical repair, which should be expedited without delay.
*Administer dobutamine 5-10 mcg/kg/min IV*
- **Dobutamine** is an inotrope that increases cardiac contractility. While it might improve cardiac output in some forms of cardiogenic shock, in the setting of **acute severe mitral regurgitation from papillary muscle rupture**, it cannot resolve the structural valvular incompetence.
- Increasing contractility may paradoxically worsen the regurgitant fraction and further compromise forward cardiac output.
- Medical management alone cannot resolve this mechanical complication, necessitating urgent surgical intervention.
Question 5: A 29-year-old man is brought to the emergency room 6 hours after the onset of severe epigastric pain and vomiting. His heart rate is 110/min and blood pressure is 98/72 mm Hg. He is diagnosed with acute pancreatitis, and fluid resuscitation with normal saline is initiated. Which of the following is the most likely immediate effect of fluid resuscitation in this patient?
A. Increase in plasma oncotic pressure
B. Increase in glomerular filtration fraction
C. Increase in volume of distribution
D. Increase in cardiac afterload
E. Increase in myocardial oxygen demand (Correct Answer)
Explanation: ***Increase in myocardial oxygen demand***
- Fluid resuscitation in a hypotensive patient with tachycardia increases **cardiac preload** and **stroke volume**, leading to higher cardiac output.
- This increased workload on the heart, especially when the patient is already tachycardic, directly translates to an **increased demand for oxygen** by the myocardium.
*Increase in plasma oncotic pressure*
- Fluid resuscitation with **normal saline** (crystalloid solution) primarily increases intravascular volume but does not significantly increase plasma proteins, which are responsible for oncotic pressure.
- In fact, large volumes of crystalloids can sometimes **slightly decrease oncotic pressure** due to hemodilution.
*Increase in glomerular filtration fraction*
- Fluid resuscitation improves **renal perfusion** and **glomerular filtration rate (GFR)** by restoring blood pressure and intravascular volume.
- However, the glomerular filtration fraction, which is the ratio of GFR to renal plasma flow, does not necessarily increase; it might even decrease as renal plasma flow improves.
*Increase in volume of distribution*
- Volume of distribution refers to the apparent volume into which a drug distributes in the body. Fluid resuscitation **increases the intravascular fluid volume**, which is part of the total body water, but this is a change in actual volume, not a change in a pharmacokinetic parameter for drug distribution.
- It would more accurately be described as increasing the **effective circulating volume**, not the **volume of distribution** in a pharmacological sense.
*Increase in cardiac afterload*
- Cardiac afterload refers to the resistance the heart must overcome to eject blood. While fluid resuscitation increases **intravascular volume**, it primarily affects **preload**.
- Although indirectly, by improving cardiac output and maintaining blood pressure, there might be a slight increase in afterload, an **increase in myocardial oxygen demand** is a more direct and immediate consequence of the increased workload.
Question 6: A 28-year-old male presents to his primary care physician with complaints of intermittent abdominal pain and alternating bouts of constipation and diarrhea. His medical chart is not significant for any past medical problems or prior surgeries. He is not prescribed any current medications. Which of the following questions would be the most useful next question in eliciting further history from this patient?
A. "Does the diarrhea typically precede the constipation, or vice-versa?"
B. "Is the diarrhea foul-smelling?"
C. "Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life"
D. "Are the symptoms worse in the morning or at night?"
E. "Can you tell me more about the symptoms you have been experiencing?" (Correct Answer)
Explanation: ***Can you tell me more about the symptoms you have been experiencing?***
- This **open-ended question** encourages the patient to provide a **comprehensive narrative** of their symptoms, including details about onset, frequency, duration, alleviating/aggravating factors, and associated symptoms, which is crucial for diagnosis.
- In a patient presenting with vague, intermittent symptoms like alternating constipation and diarrhea, allowing them to elaborate freely can reveal important clues that might not be captured by more targeted questions.
*Does the diarrhea typically precede the constipation, or vice-versa?*
- While knowing the sequence of symptoms can be helpful in understanding the **pattern of bowel dysfunction**, it is a very specific question that might overlook other important aspects of the patient's experience.
- It prematurely narrows the focus without first obtaining a broad understanding of the patient's overall symptomatic picture.
*Is the diarrhea foul-smelling?*
- Foul-smelling diarrhea can indicate **malabsorption** or **bacterial overgrowth**, which are important to consider in some gastrointestinal conditions.
- However, this is a **specific symptom inquiry** that should follow a more general exploration of the patient's symptoms, as it may not be relevant if other crucial details are missed.
*Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life*
- Quantifying pain intensity is useful for assessing the **severity of discomfort** and monitoring changes over time.
- However, for a patient with intermittent rather than acute, severe pain, understanding the **character, location, and triggers** of the pain is often more diagnostically valuable than just a numerical rating initially.
*Are the symptoms worse in the morning or at night?*
- Diurnal variation can be relevant in certain conditions, such as inflammatory bowel diseases where nocturnal symptoms might be more concerning, or functional disorders whose symptoms might be stress-related.
- This is another **specific question** that should come after gathering a more complete initial picture of the patient's symptoms to ensure no key information is overlooked.
Question 7: A 70-year-old man with severe ischemic cardiomyopathy (EF 25%) has recurrent ventricular tachycardia despite optimal medical therapy and ICD placement. Cardiac MRI shows a large anteroseptal scar with viable myocardium in the lateral and inferior walls. He has three-vessel coronary disease. His daughter is advocating for heart transplantation, but he has multiple comorbidities including obesity (BMI 37) and active tobacco use. Evaluate the management priority and rationale.
A. Left ventricular assist device as destination therapy
B. Catheter ablation of VT with continued ICD monitoring
C. Cardiac resynchronization therapy upgrade and medication adjustment
D. List for heart transplantation immediately given severe cardiomyopathy
E. CABG with surgical ventricular reconstruction and continued medical optimization (Correct Answer)
Explanation: ***CABG with surgical ventricular reconstruction and continued medical optimization***
- The patient has **three-vessel disease** and **viable myocardium** in the lateral and inferior walls; **CABG** addresses the ischemic substrate and potentially improves **LVEF**.
- **Surgical ventricular reconstruction (SVR)** addresses the large **anteroseptal scar**, reducing left ventricular volume and providing better geometric stability to mitigate **ventricular tachycardia** (VT).
*Left ventricular assist device as destination therapy*
- While **LVAD** is an option for end-stage heart failure, the presence of **active tobacco use** and **obesity** (BMI 37) are significant relative contraindications.
- **Surgical revascularization** is prioritized when significant **viable myocardium** is present and surgical targets are available.
*Catheter ablation of VT with continued ICD monitoring*
- **VT ablation** target-treats the arrhythmia but does not address the underlying **remodelling** or **ischemia** causing the progressive cardiomyopathy.
- Given the **three-vessel disease**, surgical intervention is more comprehensive for long-term prognosis compared to percutaneous ablation alone.
*Cardiac resynchronization therapy upgrade and medication adjustment*
- The patient is already on **optimal medical therapy** with an **ICD**; simple medication adjustment is unlikely to control recurrent VT in the setting of structural scar and ischemia.
- **CRT** provides limited benefit if the primary issue is a large **anteroseptal scar** and **active ischemia** requiring revascularization.
*List for heart transplantation immediately given severe cardiomyopathy*
- Direct listing is contraindicated due to **active tobacco use** and a **BMI >35**, which are standard exclusion criteria for transplant programs.
- Heart transplantation is considered a last resort after maximizing options like **revascularization** and addressing **modifiable risk factors**.
Question 8: A 49-year-old woman with myasthenia gravis undergoes CT chest showing a 5 cm anterior mediastinal mass with irregular borders. Biopsy confirms thymoma (WHO type B2). She has well-controlled myasthenic symptoms on pyridostigmine. Staging shows no distant metastases, but the mass abuts the pericardium without clear invasion. Evaluate the optimal treatment approach.
A. Thymectomy with possible en bloc pericardial resection, followed by adjuvant radiation (Correct Answer)
B. Increase immunosuppression then delayed surgery in 6 months
C. Radiation therapy alone to preserve myasthenia control
D. Immediate thymectomy followed by observation
E. Neoadjuvant chemotherapy, then thymectomy and adjuvant radiation
Explanation: ***Thymectomy with possible en bloc pericardial resection, followed by adjuvant radiation***
- Complete **surgical resection (R0)** is the cornerstone of treatment for **WHO type B2 thymomas**, especially when the mass is resectable despite abutting local structures like the **pericardium**.
- **Adjuvant radiation** is indicated for **Masaoka Stage II/III** disease or high-risk B2 histology to minimize the risk of **local recurrence**.
*Increase immunosuppression then delayed surgery in 6 months*
- Delaying surgery for a 5 cm **potentially invasive thymoma** allows for tumor progression and increases the risk of higher-stage disease.
- **Myasthenia gravis** symptoms are already **well-controlled**, making immediate surgical intervention safe and the preferred priority.
*Radiation therapy alone to preserve myasthenia control*
- **Radiation alone** is not a curative intent treatment for resectable thymoma and is usually reserved for **unresectable** or medically unfit patients.
- Thymectomy is actually a therapeutic part of managing **myasthenia gravis**, often leading to symptomatic improvement or remission.
*Immediate thymectomy followed by observation*
- Observation alone after surgery is insufficient for **B2 thymomas** that show irregular borders or high-risk features like **pericardial involvement**.
- The size over 5 cm and contact with the **pericardium** (Stage IIb/III) necessitate **postoperative radiotherapy** to improve oncologic outcomes.
*Neoadjuvant chemotherapy, then thymectomy and adjuvant radiation*
- **Neoadjuvant chemotherapy** is typically reserved for tumors deemed **primarily unresectable** on imaging, which is not the case here.
- Since the mass only **abuts** the pericardium and has no distant metastases, it is considered **upfront resectable**.
Question 9: A 58-year-old man with coronary artery disease requires CABG. Preoperative angiography shows 90% left main stenosis, 95% proximal LAD stenosis, 80% circumflex stenosis, and chronic total occlusion of the RCA with collaterals. He has diabetes, renal insufficiency (Cr 2.1), and previous stroke. Evaluate the optimal grafting strategy to maximize long-term patency and outcomes.
A. Bilateral internal mammary arteries with supplemental vein grafts
B. Off-pump CABG with sequential vein grafts only
C. LIMA to LAD, radial artery to circumflex, vein graft to RCA (Correct Answer)
D. All saphenous vein grafts to minimize operative time
E. LIMA to LAD, saphenous vein grafts to remaining vessels
Explanation: ***LIMA to LAD, radial artery to circumflex, vein graft to RCA***
- The **LIMA-to-LAD** graft is the gold standard, providing the best long-term patency and survival outcomes in multi-vessel **CABG**.
- Using a **radial artery** for the circumflex system (high-grade stenosis) offers superior patency over vein grafts while avoiding the high risk of **sternal wound infection** associated with **BIMA** in diabetic patients.
*Bilateral internal mammary arteries with supplemental vein grafts*
- While **BIMA** provides excellent patency, it is associated with a significantly increased risk of **sternal dehiscence** and infection in patients with **Diabetes Mellitus**.
- The benefit of a second arterial graft is better achieved with the **radial artery** in this high-risk comorbid profile.
*Off-pump CABG with sequential vein grafts only*
- **Sequential vein grafts** have lower long-term patency compared to arterial conduits and do not capitalize on the survival benefit of the **LIMA-to-LAD**.
- Off-pump surgery might reduce some risks but using only vein grafts is suboptimal for a 58-year-old with **long-term** survival goals.
*All saphenous vein grafts to minimize operative time*
- **Saphenous vein grafts (SVG)** have much higher failure rates (approx. 50% at 10 years) compared to **internal mammary arteries**.
- Minimizing operative time does not justify the poor long-term clinical outcomes and higher **re-intervention rates** associated with an all-SVG strategy.
*LIMA to LAD, saphenous vein grafts to remaining vessels*
- This is a standard approach, but the addition of a second arterial conduit like the **radial artery** is preferred for younger patients with high-grade stenosis to maximize **patency**.
- In the setting of **90% left main** and **80% circumflex** stenosis, the radial artery is more durable than a vein graft for the circumflex target.
Question 10: A 62-year-old man develops sudden onset of severe chest and back pain. CT angiography shows a Stanford Type B aortic dissection extending from just distal to the left subclavian artery to the iliac bifurcation. Blood pressure is 165/95 mmHg, heart rate 88/min. He has no evidence of malperfusion, rupture, or refractory pain. Analyze the initial management strategy.
A. Medical management with beta-blockers and blood pressure control (Correct Answer)
B. Fenestration procedure to improve distal perfusion
C. Observation in ICU without antihypertensive therapy
D. Emergent open surgical repair with graft replacement
E. Immediate thoracic endovascular aortic repair (TEVAR)
Explanation: ***Medical management with beta-blockers and blood pressure control***
- **Stanford Type B** aortic dissections that are **uncomplicated** (no malperfusion, rupture, or refractory pain) are primarily managed through **aggressive blood pressure** and **heart rate** control.
- **Beta-blockers** are the first-line treatment to reduce **dP/dt** (the rate of pressure rise), which decreases **aortic wall shear stress** and limits the extension of the dissection.
*Fenestration procedure to improve distal perfusion*
- This procedure is specifically indicated for **malperfusion syndrome** where the dissection creates a false lumen that compresses the true lumen supplying vital organs.
- Since this patient has **no evidence of malperfusion**, performing a fenestration at this stage is not clinically indicated or necessary.
*Observation in ICU without antihypertensive therapy*
- Simple observation is insufficient because uncontrolled hypertension and high shear stress increase the risk of **aortic rupture** and **aneurysmal expansion**.
- Rigid management aiming for a **systolic blood pressure** of 100–120 mmHg and a **heart rate** below 60/min is the mandatory gold standard.
*Emergent open surgical repair with graft replacement*
- **Open surgical repair** for Type B dissection is associated with high **morbidity and mortality** rates and is generally avoided in the acute phase unless complications like rupture occur.
- Unlike Type A dissections, which require **emergent surgery**, uncomplicated Type B dissections have better outcomes with **non-operative medical therapy**.
*Immediate thoracic endovascular aortic repair (TEVAR)*
- While TEVAR is the treatment of choice for **complicated** Type B dissections, immediate intervention is not recommended for stable patients without high-risk features.
- Clinical trials (such as **INSTEAD**) suggest that routine early TEVAR for uncomplicated cases does not improve **short-term survival** compared to optimal medical management.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
